| Particulars |
|
|
|
| Company Name
| Balaxi Pharmaceuticals Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
11.04 |
B.V. (₹) |
23.10 |
| Sales(₹ Cr.) |
70.20 |
NP (₹ Cr.) |
3.69 |
| NP Var (%) |
-77.00 |
Div% |
0.00 |
| CPS(₹) |
0.80 |
EPS (₹) |
0.70 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
151.00 |
| 52 Week Low |
49.00 |
Price BSE |
0.00 |
| Price NSE |
50.00 |
Market Capital (₹ Cr.) |
275.98 |
| P/C Ratio |
65.70 |
P/E Ratio |
74.70 |
| Price Vs.BV |
2.16 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
9.65 |
| NP(₹ Cr.) |
-1.18 |
NP Var % |
-105.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var (%) |
-48.51 |
EPS |
0.76 |
| PE |
65.78 |
|
|